Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report

BACKGROUND: Avelumab is an anti-programmed cell death ligand 1 (PD-L1) antibody approved for treatment of Merkel cell carcinoma (MCC) and locally advanced or metastatic urothelial carcinoma. It shares a similar side effect profile to other immune checkpoint inhibitors, including immune-related adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardis, Michael A., Jiang, Hong, Strauss, Julius, Gulley, James L., Brownell, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549366/
https://www.ncbi.nlm.nih.gov/pubmed/31164102
http://dx.doi.org/10.1186/s12885-019-5759-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549366/
https://www.ncbi.nlm.nih.gov/pubmed/31164102
http://dx.doi.org/10.1186/s12885-019-5759-1

Ejemplares similares